世界の腎臓透析装置開発動向:医療機器パイプライン分析2015...市場調査レポートについてご紹介

【英文タイトル】Renal Dialysis Equipment - Medical Devices Pipeline Assessment, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 10
2 Introduction 11
2.1 Renal Dialysis Equipment Overview 11
3 Products under Development 13
3.1 Renal Dialysis Equipment – Pipeline Products by Stage of Development 13
3.2 Renal Dialysis Equipment – Pipeline Products by Segment 14
3.3 Renal Dialysis Equipment – Pipeline Products by Territory 15
3.4 Renal Dialysis Equipment – Pipeline Products by Regulatory Path 16
3.5 Renal Dialysis Equipment – Pipeline Products by Estimated Approval Date 17
3.6 Renal Dialysis Equipment – Ongoing Clinical Trials 18
4 Renal Dialysis Equipment – Pipeline Products under Development by Companies 19
4.1 Renal Dialysis Equipment Companies – Pipeline Products by Stage of Development 19
4.2 Renal Dialysis Equipment – Pipeline Products by Stage of Development 22
5 Renal Dialysis Equipment Companies and Product Overview 25
5.1 3S BioMedical, Inc. Company Overview 25
5.1.1 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.2 Advanced Dialysis Methods Ltd. Company Overview 26
5.2.1 Advanced Dialysis Methods Ltd. Pipeline Products & Ongoing Clinical Trials Overview 26
5.3 AngioDynamics, Inc. Company Overview 27
5.3.1 AngioDynamics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.4 ARISTE Medical Company Overview 29
5.4.1 ARISTE Medical Pipeline Products & Ongoing Clinical Trials Overview 29
5.5 Asahi Kasei Corporation Company Overview 31
5.5.1 Asahi Kasei Corporation Pipeline Products & Ongoing Clinical Trials Overview 31
5.6 Ash Access Technology, Inc. Company Overview 34
5.6.1 Ash Access Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 34
5.7 AWAK Technologies Pte Ltd Company Overview 36
5.7.1 AWAK Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
5.8 Baxter International Inc. Company Overview 37
5.8.1 Baxter International Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.9 Blood Purification Technologies, Inc. Company Overview 46
5.9.1 Blood Purification Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.10 CatheNect Medical Company Overview 47
5.10.1 CatheNect Medical Pipeline Products & Ongoing Clinical Trials Overview 47
5.11 Chemica Technologies, Inc. Company Overview 48
5.11.1 Chemica Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.12 Chrysalis Medical Weight Loss Clinic Company Overview 49
5.12.1 Chrysalis Medical Weight Loss Clinic Pipeline Products & Ongoing Clinical Trials Overview 49
5.13 Circuport, Inc. Company Overview 50
5.13.1 Circuport, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.14 Control Medical Technology, LLC Company Overview 51
5.14.1 Control Medical Technology, LLC Pipeline Products & Ongoing Clinical Trials Overview 51
5.15 CreatiVasc Medical LLC Company Overview 52
5.15.1 CreatiVasc Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 52
5.16 Cytograft Tissue Engineering, Inc. Company Overview 55
5.16.1 Cytograft Tissue Engineering, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.17 CytoPherx, Inc. Company Overview 57
5.17.1 CytoPherx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.18 Debiotech S.A. Company Overview 58
5.18.1 Debiotech S.A. Pipeline Products & Ongoing Clinical Trials Overview 58
5.19 DEKA Research and Development Corporation Company Overview 62
5.19.1 DEKA Research and Development Corporation Pipeline Products & Ongoing Clinical Trials Overview 62
5.20 Dipylon Medical AB Company Overview 64
5.20.1 Dipylon Medical AB Pipeline Products & Ongoing Clinical Trials Overview 64
5.21 ExThera Medical LLC. Company Overview 67
5.21.1 ExThera Medical LLC. Pipeline Products & Ongoing Clinical Trials Overview 67
5.22 Fistulink Ltd. Company Overview 68
5.22.1 Fistulink Ltd. Pipeline Products & Ongoing Clinical Trials Overview 68
5.23 Flow Forward Medical, LLC Company Overview 69
5.23.1 Flow Forward Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 69
5.24 Fresenius Medical Care AG & Co. KGaA Company Overview 70
5.24.1 Fresenius Medical Care AG & Co. KGaA Pipeline Products & Ongoing Clinical Trials Overview 70
5.25 Fresenius Medical Care Holdings, Inc. Company Overview 76
5.25.1 Fresenius Medical Care Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
5.26 Georgia Institute of Technology Company Overview 78
5.26.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 78
5.27 Glomeria Therapeutics Srl Company Overview 81
5.27.1 Glomeria Therapeutics Srl Pipeline Products & Ongoing Clinical Trials Overview 81
5.28 Healionics Corporation Company Overview 84
5.28.1 Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview 84
5.29 Laminate Medical Technologies Ltd. Company Overview 85
5.29.1 Laminate Medical Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 85
5.30 Marvao Medical Devices Limited Company Overview 88
5.30.1 Marvao Medical Devices Limited Pipeline Products & Ongoing Clinical Trials Overview 88
5.31 Medtronic plc Company Overview 91
5.31.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 91
5.32 Miromatrix Medical Inc. Company Overview 93
5.32.1 Miromatrix Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 93
5.33 Nanodialysis BV Company Overview 94
5.33.1 Nanodialysis BV Pipeline Products & Ongoing Clinical Trials Overview 94
5.34 NanoVasc, Inc. Company Overview 95
5.34.1 NanoVasc, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.35 Nicast Ltd. Company Overview 96
5.35.1 Nicast Ltd. Pipeline Products & Ongoing Clinical Trials Overview 96
5.36 NuVascular Technologies Inc Company Overview 97
5.36.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 97
5.37 NxStage Medical, Inc. Company Overview 99
5.37.1 NxStage Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 99
5.38 PeriTec Biosciences, Ltd. Company Overview 104
5.38.1 PeriTec Biosciences, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 104
5.39 Phase One Medical, LLC Company Overview 105
5.39.1 Phase One Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 105
5.40 qSTAR Medical SAS Company Overview 108
5.40.1 qSTAR Medical SAS Pipeline Products & Ongoing Clinical Trials Overview 108
5.41 Quanta Fluid Solutions Ltd. Company Overview 109
5.41.1 Quanta Fluid Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 109
5.42 RenalGuard Solutions, Inc. Company Overview 110
5.42.1 RenalGuard Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 110
5.43 Senexis Limited (Inactive) Company Overview 115
5.43.1 Senexis Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 115
5.44 Surgical Specialties Corporation (Inactive) Company Overview 116
5.44.1 Surgical Specialties Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 116
5.45 TEI Biosciences, Inc. Company Overview 118
5.45.1 TEI Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 118
5.46 Tengion, Inc. (Inactive) Company Overview 119
5.46.1 Tengion, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 119
5.47 University of California, San Francisco Company Overview 121
5.47.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 121
5.48 University of Limerick Company Overview 124
5.48.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 124
5.49 Vanderbilt University Company Overview 125
5.49.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 125
5.50 Veryan Medical Limited Company Overview 127
5.50.1 Veryan Medical Limited Pipeline Products & Ongoing Clinical Trials Overview 127
5.51 Vital Access, Corp. Company Overview 128
5.51.1 Vital Access, Corp. Pipeline Products & Ongoing Clinical Trials Overview 128
5.52 Vivonics, Inc. Company Overview 129
5.52.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 129
5.53 Vizio Medical Devices Company Overview 130
5.53.1 Vizio Medical Devices Pipeline Products & Ongoing Clinical Trials Overview 130
6 Renal Dialysis Equipment- Recent Developments 131
7 Appendix 205
7.1 Methodology 205
7.2 About GlobalData 207
7.3 Contact Us 208
7.4 Disclaimer 208


【レポート販売概要】

■ タイトル:世界の腎臓透析装置開発動向:医療機器パイプライン分析2015
■ 英文:Renal Dialysis Equipment - Medical Devices Pipeline Assessment, 2015
■ 発行日:2016年1月1日
■ 調査会社:GlobalData
■ 商品コード:GDME0134EPD
■ 調査対象地域:グローバル
  • 個人用高級品の世界市場2019-2023
    About this market The influence of different marketing strategies on customers’ purchase decisions will lead the personal luxury goods market to register considerable growth in the forthcoming years. Customers are seeking value for money, especially while buying expensive products. Various luxury brand manufacturers are adopting effective marketing techniques and strategies for expanding their con …
  • 世界のプッシュトゥトーク市場:コンポーネント別(ハードウェア、ソリューション、サービス)、ネットワーク種類別(LMRおよびセルラー)、組織規模別(中小企業および大企業)、業種別(公共安全、政府および防衛、商業)、地域別
    Growing demand for PTT over Cellular (PoC) to drive the demand for Push to Talk (PTT) MarketsandMarkets forecasts the global PTT market size to grow from USD 25.0 billion in 2019 to USD 38.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 9.0% from 2019 to 2024. Major factors expected to drive the growth of the PTT market include the demand for PoC, proliferation of rugged and ultra-ru …
  • 全身性強直性間代性発作治療のグローバル臨床試験動向(2014年H2)
    Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Generalized Tonic-Clonic Seizure Global Clinical Trials Review, H2, 2014" provides data on the Generalized Tonic-Clonic Seizure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Generalized Tonic-Clonic Seizure. It inclu …
  • ワイパー装置の世界市場分析:従来式ワイパー、雨滴感知式ワイパー
    The global wiper system market is estimated to reach USD 11.07 billion by 2025, according to a new study by Grand View Research, Inc. The growing automobile production is expected to drive the market growth over the forecast period. The improved standard of living and increase in GDP in developing regions has stimulated the purchase of automotive vehicles thereby, fostering the demand for these pr …
  • 水性樹脂の世界市場:アクリル樹脂、アルキド樹脂、エポキシ樹脂、ポリウレタン樹脂
    Water-based resins technology uses water as a carrier medium and diluent instead of traditionally used VOCs (Volatile Organic Compounds). Resin products manufactured by this technology are environmentally friendly and are safer to human health due to low or zero level of VOC emissions. Resins with water-based technology possess a variety of physical and chemical properties such as better resistanc …
  • 世界のチオ硫酸ナトリウム市場2015
    The Global Sodium Thiosulphate Industry Report 2015 is a professional and in-depth study on the current state of the Sodium Thiosulphate industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Sodium Thiosulphate market analysis is provided for the international markets including development trends, compet …
  • Aortic Aneurysm:グローバル臨床試験レビューH1, 2013
    Aortic Aneurysm Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Aortic Aneurysm Global Clinical Trials Review, H1, 2013" provides data on the Aortic Aneurysm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aortic Aneurysm. It includes an overview of the trial numbers and their recruitment status as …
  • OmanのLimestone Flux, Limestone市場:貿易(輸入、輸出)動向
    This market research report examines the foreign trade of Oman and its perspectives on the global market for limestone flux, limestone. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on limestone flux, limestone export/import operations in Oman. The 2002-2012 period is …
  • ニュージーランドの発電市場2016:市場動向、制度、競争状況
    New Zealand Power Market Outlook to 2030, Update 2016 - Market Trends, Regulations, and Competitive Landscape Summary This report elaborates New Zealand's power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the New Zealand power market’s regulatory structure, import and export trends, competitive landscape, a …
  • ロシアの気道装置・麻酔装置市場
    Russia Airway and Anesthesia Devices Market Outlook to 2021 Summary GlobalData’s new report, "Russia Airway and Anesthesia Devices Market Outlook to 2021", provides key market data on the Russia Airway and Anesthesia market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Anesthesia Circuits, Anesthesia Masks, …
  • 耐放射線強化電子装置の世界市場2016-2020:衛星、アビオニクス、原子力発電炉、武器システム
    About Radiation Hardened Products The report segments the market on the basis of the end-users: governments, military, commercial, industrial, and medical. It also mentions end-user applications with respect to satellites (which are used both by the government and the military), advanced electronics used in nuclear weapons, and avionics used in the aviation industry with respect to high-altitude a …
  • アクロレンの世界市場
    Acrolein (CAS 107-02-8) Market Research Report 2013 presents comprehensive data on acrolein markets globally and regionally (Europe, Asia, North America etc.) The Acrolein (CAS 107-02-8) Market Research Report 2013 includes acrolein description, covers its application areas and related patterns. It overviews acrolein market, names acrolein producers and indicates its suppliers. Besides, the Acrole …
  • グローバルにおける糖尿病網膜症治療市場(2014-2018)
    About DR and its Treatment Types DR is defined as an eye disorder that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye which acts as a film for the formation of an image. Long-term diabetes affects the retina as a high blood glucose level can deteriorate and damage the tiny blood vessels in the retina. DR is broadly classified into either non-pro …
  • 高眼圧症(Ocular Hypertension):治療薬開発パイプライン動向(2015年上半期版)
    Ocular Hypertension - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Ocular Hypertension - Pipeline Review, H1 2015’, provides an overview of the Ocular Hypertension’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ocular Hypertension, complete with comparative analysis at various stages, therapeutics assessment by drug target, m …
  • 世界のコンフォーマルコーティング装置市場2015
    The Global Conformal Coatings Equipmnet Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Conformal Coatings Equipmnet industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Conformal Coatings Equipmnet market analysis is provided for the international m …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。